2004
DOI: 10.1016/j.pbi.2004.01.007
|View full text |Cite
|
Sign up to set email alerts
|

Plant-based production of biopharmaceuticals

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
355
0
6

Year Published

2005
2005
2012
2012

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 566 publications
(376 citation statements)
references
References 61 publications
1
355
0
6
Order By: Relevance
“…Technical advances and limitations of plant-based protein production systems have been recently detailed in (Fischer et al, 2004). We showed here a high yield (2.3% TSP) obtained with a cytosolic protein-expression system.…”
Section: Biotechnological Applicationsmentioning
confidence: 77%
“…Technical advances and limitations of plant-based protein production systems have been recently detailed in (Fischer et al, 2004). We showed here a high yield (2.3% TSP) obtained with a cytosolic protein-expression system.…”
Section: Biotechnological Applicationsmentioning
confidence: 77%
“…However, these systems have several disadvantages in terms of cost, stability, safety, etc (Fischer et al, 2004). Plants offer an alternative to microbial fermentation and animal cell cultures and are now gaining widespread acceptance as a general platform for the large-scale production of recombinant proteins (Streatfi eld, 2007).…”
Section: Introductionmentioning
confidence: 99%
“…Plants offer an alternative to microbial fermentation and animal cell cultures and are now gaining widespread acceptance as a general platform for the large-scale production of recombinant proteins (Streatfi eld, 2007). Plants are the most economical producers of biomass and allow for cost-effective production of recombinant proteins on an agricultural scale (Fischer et al, 2004;Berberich et al, 2005). They avoid animal or microbial cell-culture contaminants, such as mammalian pathogens or bacterial components (Fischer et al, 2004;Ma et al, 2003).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Following the first report of successful production of a mouse monoclonal antibody in a plant (Hiatt et al 1989), many other therapeutic proteins have been expressed in transgenic plants. In general, four approaches have been considered for developing molecular farming system in crop species (Fischer et al 2004): nuclear transformation, plastid (chloroplast) transformation, virus-mediated transient transformation, and stable transformation of hydroponically-grown plant species.…”
Section: Introductionmentioning
confidence: 99%